These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3927322)

  • 21. Intraventricular 6-hydroxydopamine increases thyrotropin-releasing hormone (TRH) content in regions of rat brain.
    Engber TM; Manaker S; Kreider MS; Winokur A
    Regul Pept; 1985 Sep; 12(1):51-7. PubMed ID: 3934717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
    Hard E; Ahlenius S; Engel J
    Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the CNS effects induced by TRH and bicuculline after microinjection into medial septum, substantia nigra and inferior colliculus: absence of support for a GABA antagonist action for TRH.
    Breese GR; Frye GD; McCown TJ; Mueller RA
    Pharmacol Biochem Behav; 1984 Jul; 21(1):145-9. PubMed ID: 6431450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early postnatal administration of 5,7-dihydroxytryptamine: effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain.
    Towle AC; Breese GR; Mueller RA; Hunt R; Lauder JM
    Brain Res; 1986 Jan; 363(1):38-46. PubMed ID: 2418913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats.
    Samanin R; Bernasconi S; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):377-80. PubMed ID: 1234558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats.
    Mueller RA; Towle AC; Breese GR
    Brain Res; 1984 Apr; 298(2):370-3. PubMed ID: 6426700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pressor and sympathetic responses to dorsal raphe nucleus infusions of TRH in rats.
    Mattila J; Buñag RD
    Am J Physiol; 1990 Jun; 258(6 Pt 2):R1464-71. PubMed ID: 2113776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of modification of brain serotonin (5-HT) on ethanol tolerance.
    Khanna JM; Kalant H; Le AD; LeBlanc AE
    Alcohol Clin Exp Res; 1979 Oct; 3(4):353-8. PubMed ID: 391088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
    Waller SB; Buterbaugh GG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct action of ethanol on pituitary prolactin secretion in vitro.
    Alfonso M; Marcó J; Balvis IA; Pazo JA
    Rev Esp Fisiol; 1991 Sep; 47(3):133-40. PubMed ID: 1798856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
    Narumi S; Nagawa Y
    Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone.
    Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A
    Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction.
    London ED; Buterbaugh GG
    J Pharmacol Exp Ther; 1978 Jul; 206(1):81-90. PubMed ID: 307060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
    Engler D; Chad D; Jackson IM
    J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin-releasing hormone reverses the supersensitively depressed monosynaptic transmission by serotonin in 5,7-dihydroxytryptamine-treated neonatal rats in vitro.
    Deshpande SB; Warnick JE
    Brain Res; 1994 Aug; 655(1-2):263-6. PubMed ID: 7812785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.